Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G de Groot

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysisT Lisman, P G De Groot
Journal of Autoimmunity|September 2, 2000
Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?R H Derksen, P G de Groot
British Journal of Haematology|July 1, 1990
Platelet adhesionP G de Groot, J J Sixma
Thrombosis Research|December 15, 1992
The ideal anti-thrombotic drugJ J Sixma, P G de Groot
Seminars in Thrombosis and Hemostasis|January 1, 1992
Endothelial cell-mediated thrombin formationP N Tijburg, P G de Groot
Annals of the New York Academy of Sciences|April 18, 1994
Regulation of platelet adhesion to the vessel wallJ J Sixma, P G de Groot
Journal of Thrombosis and Haemostasis : JTH|March 12, 2014
Cellular signaling by antiphospholipid antibodiesP G de Groot, R T Urbanus
Seminars in Thrombosis and Hemostasis|October 1, 1987
Role of von Willebrand factor in the vessel wallP G de Groot, J J Sixma
Mayo Clinic Proceedings|June 1, 1991
von Willebrand factor and the blood vessel wallJ J Sixma, P G de Groot
Haemostasis|January 1, 1988
Interaction of blood platelets with the vessel wallP F Nievelstein, P G de Groot
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysisT Lisman, P G De Groot
Journal of Autoimmunity|September 2, 2000
Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?R H Derksen, P G de Groot
British Journal of Haematology|July 1, 1990
Platelet adhesionP G de Groot, J J Sixma
Thrombosis Research|December 15, 1992
The ideal anti-thrombotic drugJ J Sixma, P G de Groot
Seminars in Thrombosis and Hemostasis|January 1, 1992
Endothelial cell-mediated thrombin formationP N Tijburg, P G de Groot
Annals of the New York Academy of Sciences|April 18, 1994
Regulation of platelet adhesion to the vessel wallJ J Sixma, P G de Groot
Journal of Thrombosis and Haemostasis : JTH|March 12, 2014
Cellular signaling by antiphospholipid antibodiesP G de Groot, R T Urbanus
Seminars in Thrombosis and Hemostasis|October 1, 1987
Role of von Willebrand factor in the vessel wallP G de Groot, J J Sixma
Mayo Clinic Proceedings|June 1, 1991
von Willebrand factor and the blood vessel wallJ J Sixma, P G de Groot
Haemostasis|January 1, 1988
Interaction of blood platelets with the vessel wallP F Nievelstein, P G de Groot
Pageof 28